IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q4 2018 Holdings

Filed 2019-02-12 | 23 holdings | $440.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bio-Rad Laboratories(BIO)COM090572207$405.0K1,74591.9%
Insmed Inc(INSM)COM457669307$4.9K373,1981.1%
Global Blood Therapeutics IncCOM37890U108$4.4K106,6841.0%
PTC Therapeutics(PTCT)COM69366J200$3.8K110,7940.9%
Portola Pharmaceuticals IncCOM737010108$3.3K170,1290.8%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$2.1K57,4860.5%
Incyte Corp(INCY)COM45337C102$2.0K31,5880.5%
Centene Corp(CNC)COM15135B101$1.9K16,1890.4%
Unitedhealth Group Inc(UNH)COM91324P102$1.7K6,8840.4%
Neurocrine Biosciences Inc(NBIX)COM64125C109$1.5K20,5710.3%
CVS Caremark Corp(CVS)COM126650100$1.4K21,7390.3%
Inogen Inc(INGN)COM45780L104$1.3K10,0720.3%
Penumbra Inc(PEN)COM70975L107$1.2K9,9660.3%
Davita Healthcare Partners I(DVA)COM23918K108$1.1K21,1560.2%
Amicus Therapeutics Inc(FOLD)COM03152W109$93297,2940.2%
Acceleron Pharma Inc(XLRN)COM00434H108$80818,5640.2%
Heron Therapeutics(HRTX)COM427746102$80130,8610.2%
Nucana PLCADR67022C106$62443,0470.1%
Viewray Inc(VRAYQ)COM92672L107$58996,9640.1%
Verrica Pharmaceuticals IncCOM92511W108$51262,8820.1%
Equillium Inc(EQ)COM29446K106$49760,8820.1%
Kadmon Holdings Inc(KDMN)COM48283N106$401192,6370.1%
Durect Corporation(DRRXEUR)COM266605104$111228,8200.0%